|
EARNINGS REPORT by CSIMarket
Deficit Bigger Than a Year Ago, Sales Faded
Perceptron Inc announced most recent fiscal period operating deficit of $-0.697 millions
 Weak demand caused increase in losses for the most recent fiscal period, company's loss per share grew to $ -0.04 from $0.06 where Sales fell by -21.94 % to $ 14 millions from $18 millions a year ago. In contrast to the fourth quarter 2020 Sales advanced by 10.52 % from $13 millions and improved from $ -0.15 per share. For the most recent fiscal period Perceptron Inc logged net loss of $ -0.407 million, instead of break-even in the same quarter a year before.
|
Recently Reported Results |
![Base_station_installation_telenor_norway_By_HLundgaard_(Own_work)__[CC-BY-SA-3.0_(http_creativecommons.org_licenses_by-sa_3.0)]_via_Wikimedia_Common](../news/img/communication/Base_station_installation_telenor_norway_By_HLundgaard_(Own_work)__[CC-BY-SA-3.0_(http_creativecommons.org_licenses_by-sa_3.0)]_via_Wikimedia_Common.jpg "Base_station_installation_telenor_norway_By_HLundgaard_(Own_work)__[CC-BY-SA-3.0_(http_creativecommons.org_licenses_by-sa_3.0)]_via_Wikimedia_Common")
Infinera Corp
Lower demand led to lower revenues and higher loss, in the most recent fiscal period company decreased loss to $-0.05 per share, while Sales fell by -8.07% to $353.53 millions, year on year.
In the previous quarter company realized Sales of $340.21 millions and bottom line of $-0.19 per share.
Infinera Corp reported net loss of $-206.72 millions and Sales of $1.36 billions for the fiscal year 2020.
Company has decreased loss per share to $-1.10 from $-2.16 in the previous fiscal year, while Sales increased by 4.37 % from $1.30 billions a year ago.
INFN stock quotes, charts, profile
Growth Rates, Profitability, PE
|
Durable Goods Orders
New orders increased on the faster pace again, excluding defense booking grew even faster 1.05 %. That category excludes defense and gives a better indication of longer-term trends in the private sector.
|
Bluelinx Holdings Inc
Due to strong revenue growth company turned into profitability, Sales grew by 25.07% to $848.82 millions, earnings per share were at $2.77, compared to $-0.75 in the same quarter a year ago.
Sequentially profit plummeted by -51.6% from $5.72 per share and Sales decreased by -2.55% from $871.06 millions.
Bluelinx Holdings Inc reported earnings of $80.88 millions and Sales of $3.10 billions for the fiscal year 2020.
Company reported earnings per share of $8.55 compared to $-1.89 in the previous fiscal year, while Sales improved by 17.44 % from $2.64 billions a year ago.
BXC stock quotes, charts, profile
Growth Rates, Profitability, PE
|
![gas_station_By_Xnatedawgx_(Own_work)__[CC-BY-SA-3.0_(http_creativecommons.org_licenses_by-sa_3.0)]_via_Wikimedia_Commons](../news/img/oil/gas_station_By_Xnatedawgx_(Own_work)__[CC-BY-SA-3.0_(http_creativecommons.org_licenses_by-sa_3.0)]_via_Wikimedia_Commons.jpg "gas_station_By_Xnatedawgx_(Own_work)__[CC-BY-SA-3.0_(http_creativecommons.org_licenses_by-sa_3.0)]_via_Wikimedia_Commons")
Calumet Specialty Products Partners L p
Weak demand caused increase in losses for the fourth quarter of 2020 earnings season, company's deficit per share grew to $-0.51 from $-0.48 where Sales fell by -28.51% to $553.90 millions from $774.80 millions a year ago.
In contrast to the third quarter Sales decreased by -2.48% from $568.00 millions and improved from $-0.70 per share.
Calumet Specialty Products Partners L P reported net loss of $-149.00 millions and Sales of $2.27 billions for the fiscal year 2020.
Net loss per share has widen to $-1.86 from $-0.55 in previous fiscal year, while Sales Tumbled by -34.3 % from $3.45 billions a year ago.
CLMT stock quotes, charts, profile
Growth Rates, Profitability, PE
|
![8381791238_4cf7083ed0_b[CC-BY-SA-3.0_(http_creativecommons.org_licenses_by-sa_3.0)]_via_Wikimedia_Commons](../news/img/services/8381791238_4cf7083ed0_b.jpg "8381791238_4cf7083ed0_b[CC-BY-SA-3.0_(http_creativecommons.org_licenses_by-sa_3.0)]_via_Wikimedia_Commons")
Kallo Inc
In the fourth quarter of 2020 Kallo Inc increased losses of $-0.03 per share compared to $-0.00 a year ago and increased losses from $-0.01 per share from the previous quarter.
Kallo Inc reported operating deficit of $-35.557435 millions, in the fourth quarter of 2020, a deterioration from the operating loss of $-1.728984 millions, realized in fourth quarter of 2019
Kallo Inc reported net loss of $-36.06 millions and Sales of $0.00 millions for the fiscal year 2020.
Net loss per share has widen to $-0.03 from $-0.01 in previous fiscal year, while by 0 % from $0.00 millions a year ago.
KALO stock quotes, charts, profile
Growth Rates, Profitability, PE
|
Factory Orders
Factory orders continued to grow, excluding defense, booking grew even faster 1.56 %. That category excludes defense and gives a better indication of longer-term trends in the private sector.
|
Gross Domestic Product
The Gross domestic product, the measurement of the nations output, improved in the fourth-quarter, as private domestic investments and foreign demand for American products pick up.
|
Industrial production
The industrial production growth rate accelerated compare to the slow down in previous month, due to increase in growing output at utilities.
|
![pills_blue_By_Tom_Varco_(Own_work)_[CC-BY-SA-3.0_(http_creativecommons.org_licenses_by-sa_3.0)]_via_Wikimedia_Commons](../news/img/healthcare/pills_blue_By_Tom_Varco_(Own_work)_[CC-BY-SA-3.0_(http_creativecommons.org_licenses_by-sa_3.0)]_via_Wikimedia_Commons.jpg "pills_blue_By_Tom_Varco_(Own_work)_[CC-BY-SA-3.0_(http_creativecommons.org_licenses_by-sa_3.0)]_via_Wikimedia_Commons")
Ampio Pharmaceuticals inc
In the fiscal time frame ending Dec 31 2020 Ampio Pharmaceuticals Inc loss increased of $-0.02 per share compared to $-0.01 a year ago and from $-0.02 per share from the previous quarter.
Ampio Pharmaceuticals Inc reported operating loss of $-3.911 millions, in the fiscal time frame ending Dec 31 2020, an improvement from the operating shortfall of $-7.145966 millions, realized in fourth quarter of 2019
Ampio Pharmaceuticals Inc reported net loss of $-15.89 millions and Sales of $0.00 millions for the fiscal year 2020.
Company has decreased loss per share to $-0.09 from $-0.14 in the previous fiscal year, while by 0 % from $0.00 millions a year ago.
AMPE stock quotes, charts, profile
Growth Rates, Profitability, PE
|
Cowen inc
Cowen Inc delivered very strong results in the most recent fiscal period, where Sales soared by 78.89% to $502.92 millions, while company's earnings per share soared by 2512.48 % to $3.00 per share, from the same quarter a year ago.
In contrast to the third quarter Sales improved by 29.71 % from $387.74 millions and eps more than doubled by 383.3 % from $0.62 per share.
In the fiscal year 2020, Cowen Inc reported Sales of $1.62 billions and net income of $207.06 millions.
Eps surged by 1145.61 % to $7.10 per share from $0.57 in the previous fiscal year, while Sales surged by 54.68 % from $1.05 billions a year ago.
COWN stock quotes, charts, profile
Growth Rates, Profitability, PE
|
Brown forman Corporation
Brown Forman Corporation reported declining eps on increasing revenue in the financial period ending Jan 31 2021, where Sales grew by 3.74% to $1.22 billions in comparison to $1.18 billions on a year-over-year basis, while earnings decreased by -6.25% to $0.45 per share, income per share was $0.48 in the same quarter a year ago.
In the previous quarter company realized Sales of $1.27 billions and bottom line of $0.50 per share.
BFA stock quotes, charts, profile
Growth Rates, Profitability, PE
|
![Petit_dejeuner_Bordeaux_By_LenaRosemberg_User_Lena_(Flickr_Bordeaux_9584)__[CC-BY-SA-2.0_(http_creativecommons.org_licenses_by-sa_2.0)]_via_Wikimedia_Commons](../news/img/drinks/Petit_dejeuner_Bordeaux_By_LenaRosemberg_User_Lena_(Flickr_Bordeaux_9584)__[CC-BY-SA-2.0_(http_creativecommons.org_licenses_by-sa_2.0)]_via_Wikimedia_Commons.jpg "Petit_dejeuner_Bordeaux_By_LenaRosemberg_User_Lena_(Flickr_Bordeaux_9584)__[CC-BY-SA-2.0_(http_creativecommons.org_licenses_by-sa_2.0)]_via_Wikimedia_Commons")
Annovis Bio Inc
For the fourth quarter of 2020 Annovis Bio Inc lost money at $-0.25 per share, compared to results of $-0.87 per share a year ago quarter, In the previous quarter company realized $-0.15 per share.
from $0.00 millions in preceding quarter, increased losses from $-0.15 per share.
Annovis Bio Inc reported net loss of $-5.46 millions and Sales of $-0.03 millions for the fiscal year 2020.
Company recorded loss per share of $-0.87 compared to $1.73 in the previous fiscal year, while by -100 % from $4.28 billions a year ago.
ANVS stock quotes, charts, profile
Growth Rates, Profitability, PE
|
Soleno Therapeutics Inc
In the fourth quarter of 2020 Soleno Therapeutics Inc decreased loss of $-0.04 per share compared to $-0.35 a year ago and improved from $-0.11 per share from the previous quarter.
Soleno Therapeutics Inc reported operating deficit of $-7.957 millions, in the fourth quarter of 2020, a deterioration from the operating loss of $-6.752 millions, realized in fourth quarter of 2019
Soleno Therapeutics Inc reported net loss of $-24.64 millions and Sales of $0.00 millions for the fiscal year 2020.
Company has decreased loss per share to $-0.39 from $-0.90 in the previous fiscal year, while by 0 % from $0.00 millions a year ago.
SLNO stock quotes, charts, profile
Growth Rates, Profitability, PE
|
![Surgery_By_NathanGrohmann_(Own_work)_[[CC-BY-SA-3.0_(http_creativecommons.org_licenses_by-sa_3.0)]_via_Wikimedia_Commons](../news/img/healthcare/Surgery_By_NathanGrohmann_(Own_work)_[[CC-BY-SA-3.0_(http_creativecommons.org_licenses_by-sa_3.0)]_via_Wikimedia_Commons.jpg "Surgery_By_NathanGrohmann_(Own_work)_[[CC-BY-SA-3.0_(http_creativecommons.org_licenses_by-sa_3.0)]_via_Wikimedia_Commons")
Optinose Inc
Company lost money at $-0.46 per share in the fourth quarter of 2020, although its Sales surged by 47.52% to $16.35 millions from the same quarter a year ago.
In the previous quarter company realized Sales of $15.44 millions and $-0.43 per share.
Optinose Inc reported net loss of $-99.79 millions and Sales of $49.12 millions for the fiscal year 2020.
Company has decreased loss per share to $-2.07 from $-2.63 in the previous fiscal year, while Sales surged by 41.83 % from $34.63 millions a year ago.
OPTN stock quotes, charts, profile
Growth Rates, Profitability, PE
|
|
|
|
|
|
|
